Loading…
Structure Therapeutics Inc. is projected to rise to $51.76 by 2027, a +5% move from its current price of $49.12. GPCR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/25/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 26 | $47.73 | $49.13 | $50.56 | +0.01% |
| Jul 27 | $47.17 | $49.13 | $51.18 | +0.02% |
| Jul 28 | $46.74 | $49.14 | $51.66 | +0.03% |
| Jul 29 | $46.38 | $49.14 | $52.06 | +0.05% |
| Jul 30 | $46.08 | $49.15 | $52.43 | +0.06% |
| Jul 31 | $45.80 | $49.15 | $52.76 | +0.07% |
| Aug 1 | $45.54 | $49.16 | $53.06 | +0.08% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $45.54 | $49.16 | $53.06 | +0.08% |
| Week 2 | $44.16 | $49.20 | $54.81 | +0.16% |
| Week 3 | $43.14 | $49.24 | $56.20 | +0.24% |
| Week 4 | $42.30 | $49.28 | $57.41 | +0.32% |
| Week 5 | $41.57 | $49.32 | $58.50 | +0.40% |
| Week 6 | $40.93 | $49.36 | $59.51 | +0.48% |
| Week 7 | $40.36 | $49.40 | $60.46 | +0.56% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Structure Therapeutics Inc. is a clinical stage global biopharmaceutical company that develops and delivers novel oral small molecule therapeutics to treat chronic diseases with unmet medical needs in the United States. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, which is in two phase 2 clinical trials for the treatment of obesity, overweight, and related conditions.
The company also develops ACCG-2671 and ACCG-3535, ANPA-0073, LTSE-2578, and programs in glucose-dependent insulinotropic polypeptide receptor (GIPR) modulation and glucagon receptor (GCG) direction. Structure Therapeutics was incorporated in 2016 and is headquartered in South San Francisco, California.
Structure Therapeutics Inc., symbol GPCR, is currently priced at $49.35, with a market capitalization of $3.51B. It is ranked 1631 in market capitalization. The current price and market stance sit within a framework that the multi-year forecast envisions a rising average price and expanding ROI through 2050.
The near-term forecast begins at an average price of $49.35 in 2026 and projects a bullish path thereafter.
A major floor 29.7% below — a decisive break under it would weaken the trend.
The nearest floor, 15.5% below — buyers have tended to step in here.
The nearest ceiling, 15.3% above — a clean break opens room to run.
A major ceiling 31.8% above — clearing it would confirm fresh momentum.
Key GPCR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GPCR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $49.20 | Sell | $49.82 | Sell |
| MA 10 | $49.73 | Sell | $49.98 | Sell |
| MA 20 | $51.38 | Sell | $49.60 | Sell |
| MA 50 | $44.78 | Buy | $47.91 | Buy |
| MA 100 | $47.47 | Buy | $48.56 | Buy |
| MA 200 | $51.38 | Sell | $47.03 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 54.94 | Neutral |
| Stoch RSI (14) | 33.91 | Neutral |
| CCI (20) | -16.36 | Neutral |
| Williams %R (14) | -55.00 | Info |
| MACD (12,26,9) | -0.62 | Sell |
| ROC (12) | -10.29 | Sell |
| Bollinger %B (20,2) | 0.45 | Neutral |
| Stochastic %K (14) | 45.00 | Neutral |
| TRIX (15) | 0.58 | Buy |
| Awesome (5,34) | 1.39 | Buy |
| Ultimate (7,14,28) | 50.20 | Neutral |
| Momentum (10) | -4.34 | Sell |
| Aroon Osc (25) | 52.00 | Buy |
| Hull MA (9) | 49.75 | Sell |
| ADX (14) | 23.06 | Buy |
| ATR (14) | 1.43 | Info |
The near-term technical picture is NEUTRAL. RSI14 is 50, indicating balanced momentum. The stock trades around the 50-day simple moving average at $44.30 and the 200-day simple moving average at $51.14.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $35.88 | $49.12 | $64.14 | 0% | Neutral | |
| $41.04 | $51.76 | $69.17 | +5% | Neutral | |
| $49.00 | $63.68 | $88.51 | +30% | Bullish | |
| $56.01 | $74.62 | $106.92 | +52% | Bullish | |
| $61.83 | $84.20 | $123.77 | +71% | Bullish | |
| $66.55 | $92.45 | $138.96 | +88% | Bullish | |
| $63.63 | $90.05 | $138.08 | +83% | Bullish | |
| $68.40 | $98.50 | $153.79 | +101% | Bullish | |
| $71.36 | $104.48 | $165.85 | +113% | Bullish | |
| $72.20 | $107.41 | $173.15 | +119% | Bullish | |
| $99.52 | $159.14 | $273.58 | +224% | Bullish | |
| $193.50 | $350.71 | $661.96 | +614% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $35.88 | $49.12 | $58.27 | +0.00% |
| August 2026 | $41.85 | $49.27 | $59.49 | +0.31% |
| September 2026 | $41.81 | $49.64 | $60.72 | +0.74% |
| October 2026 | $43.36 | $51.84 | $64.10 | +4.44% |
| November 2026 | $43.58 | $52.39 | $65.35 | +1.07% |
| December 2026 | $42.21 | $51.01 | $64.14 | -2.63% |
Click any year to see its month-by-month GPCR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, GPCR could reach as high as $64.14, with a base case around $49.12 and support toward $35.88 — roughly 0% from $49.12. A consolidation phase looks the most probable path here.
Expect GPCR to range from $41.04 to $69.17 through 2027. The $51.76 average target implies a +5% move from current prices. That is up +5% on the projected 2026 average. Price action looks broadly range-bound.
The GPCR price prediction for 2028 points to an average of $63.68 (low $49.00, high $88.51) — a potential gain of +30% on today's $49.12. Buyers look set to stay in control over this stretch.
In 2029, GPCR is projected to trade between $56.01 and $106.92, averaging $74.62 — a potential gain of +52% from today's $49.12. That is up +17% on the projected 2028 average. Momentum favours further upside here.
Structure Therapeutics Inc.'s 2030 outlook centres on $84.20, within a $61.83 to $123.77 range. That is up +13% on the projected 2029 average. That marks a +71% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, GPCR could reach as high as $138.96, with a base case around $92.45 and support toward $66.55 — roughly +88% from $49.12. Momentum favours further upside here.
Expect GPCR to range from $63.63 to $138.08 through 2032. The $90.05 average target implies a +83% move from current prices. That is -3% versus the projected 2031 average. Buyers look set to stay in control over this stretch.
The GPCR price prediction for 2033 points to an average of $98.50 (low $68.40, high $153.79) — a potential gain of +101% on today's $49.12. Momentum favours further upside here.
In 2034, GPCR is projected to trade between $71.36 and $165.85, averaging $104.48 — a potential gain of +113% from today's $49.12. That is up +6% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Structure Therapeutics Inc.'s 2035 outlook centres on $107.41, within a $72.20 to $173.15 range. That is up +3% on the projected 2034 average. That marks a +119% change versus current levels. Momentum favours further upside here.
By 2040, GPCR could reach as high as $273.58, with a base case around $159.14 and support toward $99.52 — roughly +224% from $49.12. Buyers look set to stay in control over this stretch.
Expect GPCR to range from $193.50 to $661.96 through 2050. The $350.71 average target implies a +614% move from current prices. That is up +120% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in GPCR today (≈ 20.358306 GPCR) could be worth
$7,139.93
+$6,139.93 (+614%) by 2050 · US Dollar
Based on the average projected GPCR price of $350.71 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GPCRwould be worth at today's price.
$1,000 invested in GPCR on Jul 23, 2025 (≈ 55.06608 GPCR) would be worth
$2,704.85
+$1,704.85 (+170.5%) today · 2.70× · US Dollar
Based on a GPCR entry price of $18.16 vs. today's $49.12.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $46.03 | $1,067.13 | +6.7% |
| 1 month ago | $45.61 | $1,076.96 | +7.7% |
| 3 months ago | $45.49 | $1,079.8 | +8.0% |
| 6 months ago | $90.37 | $543.54 | -45.6% |
| 1 year ago | $18.16 | $2,704.85 | +170.5% |
| All time (3.5y) ago | $26 | $1,889.23 | +88.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GPCR forecast.
Our base-case forecast reaches $98.00 around 2033.
Implied market cap at $98.00: $6.97B
The multi-year forecast shows a bullish trajectory beginning in 2028, with the average price rising to $61.03 in 2028, $70.79 in 2029, and $79.91 in 2030, alongside rising ROIs (22.7%–61.9% through 2030). The 2030 average of $79.91 carries an ROI of 61.9%. By 2035 the average reaches $95.89 with ROI 94.3%.
By 2040 the average climbs to $140.91 with ROI 185.5%, and by 2050 the average is $304.28 with ROI 516.6%, all within a bullish sentiment in the later years.
Tap a question to reveal the answer.
The forecast shows an average price of $79.91 in 2030 with a min of $58.13 and a max of $118.74, and a projected ROI of 61.9%. The sentiment is BULLISH.
Forecasts indicate a bullish outlook from 2028 onward, with average prices rising to $304.28 by 2050 and ROI up to 516.6%. Earlier years show rising averages with continued bullish sentiment from 2028 to 2050.
Yes. The 2029 maximum is $102.43 and the 2030 maximum is $118.74, indicating values above $100 in the forecast. Note these are estimates, not guarantees.
The current price is $49.35 and the market capitalization is $3.51B.
The near-term outlook is neutral with RSI 50. The 30-day range runs from $40.41 to $60.27, with support at $37.77 and resistance at $56.63.
Structure Therapeutics Inc. Community Discussion
0Share your Structure Therapeutics Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.